120
Participants
Start Date
August 31, 2016
Primary Completion Date
August 31, 2021
Study Completion Date
August 31, 2021
Crenolanib
Placebo
Fox Chase Cancer Center, Philadelphia
Istituto Nazionale Tumori, Milan
Duke Cancer Institute, Durham
University of Miami, Miami
Mannheim University Medical Centre, University of Heidelberg, Mannheim
Centre Leon Berard, Lyon
MD Anderson Cancer Center, Houston
Sarcoma Oncology Center, Santa Monica
Oregon Health and Science University, Portland
Institut Bergonie, Bordeaux
La Timone University Hospital, Marseille
Centre Hospitalier Universitaire (CHU) de Reims, Reims
HELIOS Klinikum Berlin-Buch, Berlin
Universitätsklinikum München, Munich
Policlinico S. Orsola-Malpighi, Bologna
Institut Regina Elena / IFO, Rome
Candiolo Cancer Institute - FPO, IRCCS, Turin
University Hospital The Norwegian Radium Hospital, Oslo
M Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw
Vall d'Hebron University Hospital, Barcelona
Hospital Universitario Puerta de Hierro, Madrid
Hospital Virgen del Rocio, Seville
Fundación Instituto Valenciano de Oncología, Valencia
Lead Sponsor
Centre Leon Berard
OTHER
Fox Chase Cancer Center
OTHER
Arog Pharmaceuticals, Inc.
INDUSTRY